Key points are not available for this paper at this time.
Key Points Neutralization of IFN-γ with emapalumab can reverse severe, refractory hemophagocytic lymphohistiocytosis. Neutralizing IFN-γ did not impair control of multiple viral and other infections in a severely ill patient.
Lounder et al. (Mon,) studied this question.